4.5 Article

Deliberately Losing Control of C-H Activation Processes in the Design of Small-Molecule-Fragment Arrays Targeting Peroxisomal Metabolism

期刊

CHEMMEDCHEM
卷 15, 期 24, 页码 2513-2520

出版社

WILEY-V C H VERLAG GMBH
DOI: 10.1002/cmdc.202000543

关键词

-

资金

  1. EPSRC/AZ PhD studentship [EP/M507568/1]
  2. AstraZeneca [14550001]
  3. Tocris Biosciences
  4. EPSRC [EP/P026990/1]
  5. AbbVie
  6. Bayer Pharma AG
  7. Boehringer Ingelheim
  8. Canada Foundation for Innovation
  9. Eshelman Institute for Innovation
  10. Genome Canada
  11. Innovative Medicines Initiative (EU/EFPIA)[ULTRA-DD grant] [115766]
  12. Janssen
  13. Merck KGaA Darmstadt Germany
  14. MSD
  15. Novartis Pharma AG
  16. Ontario Ministry of Economic Development and Innovation
  17. Pfizer
  18. FAPDF
  19. CAPES
  20. CNPq
  21. Sao Paulo Research Foundation-FAPESP
  22. Takeda
  23. Wellcome [106169/ZZ14/Z]
  24. EPSRC [EP/P026990/1] Funding Source: UKRI

向作者/读者索取更多资源

Combined photochemical arylation, nuisance effect (SNAr) reaction sequences have been employed in the design of small arrays for immediate deployment in medium-throughput X-ray protein-ligand structure determination. Reactions were deliberately allowed to run out of control in terms of selectivity; for example theortho-arylation of 2-phenylpyridine gave five products resulting from mono- and bisarylations combined with SNAr processes. As a result, a number of crystallographic hits against NUDT7, a key peroxisomal CoA ester hydrolase, have been identified.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据